salsolinol has been researched along with Disease Models, Animal in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (44.44) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, S; Chen, X; Chen, Z; Deng, Y; Guo, M; Huang, Y; Liu, K; Sun, F; Zheng, X; Zhong, R | 1 |
| Deng, YL; Li, HM; Li, YJ; Meng, LY; Schläppi, M; Song, DW; Xie, BJ; Xin, N | 1 |
| Bugajski, A; Bujak-Gizycka, B; Gil, K; Kurnik, M; Madej, J; Thor, P | 1 |
| Bae, ON; Chung, JH; Chung, SM; Hong, S; Kim, K; Kim, YD; Lim, KM; Noh, JY; Shin, S; Yoon, JH | 1 |
| Banach, T; Kania, D; Thor, PJ; Zurowski, D | 1 |
| Dostert, P; Maruyama, W; Naoi, M | 1 |
| Dostert, P; Hashizume, Y; Maruyama, W; Nakahara, D; Naoi, M; Ota, M; Takahashi, T | 1 |
| Naoi, M | 1 |
| Dostert, P; Kasamatsu, T; Maruyama, W; Naoi, M | 1 |
2 review(s) available for salsolinol and Disease Models, Animal
| Article | Year |
|---|---|
Dopamine-derived 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolines; oxidation and neurotoxicity.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain; Disease Models, Animal; Dopamine; Isoquinolines; Monoamine Oxidase | 1995 |
[Neurotoxin candidates as pathogenic agents of Parkinson's disease].
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain; Brain Chemistry; Disease Models, Animal; Humans; Isoquinolines; Neurotoxins; Parkinson Disease; Rats | 1997 |
7 other study(ies) available for salsolinol and Disease Models, Animal
| Article | Year |
|---|---|
Changes in salsolinol production and salsolinol synthase activity in Parkinson's disease model.
Topics: Animals; Brain; Cell Line, Tumor; Cell Survival; Disease Models, Animal; Dopamine; Humans; Isoquinolines; Lyases; Male; Nerve Tissue Proteins; Oxidative Stress; Parkinson Disease; Rats, Sprague-Dawley | 2018 |
Formation of a salsolinol-like compound, the neurotoxin, 1-acetyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, in a cellular model of hyperglycemia and a rat model of diabetes.
Topics: Animals; Diabetes Complications; Diabetes Mellitus, Experimental; Disease Models, Animal; Dopaminergic Neurons; Glucose; Hydroxyl Radical; Hyperglycemia; Isoquinolines; Neurotoxins; Parkinson Disease; Rats; Tetrahydroisoquinolines | 2014 |
The influence of salsolinol on basic rat metabolism.
Topics: Adipose Tissue; Adult; Animals; Body Weight; Cholesterol; Disease Models, Animal; Eating; Enteric Nervous System; Gastric Emptying; Gastrointestinal Diseases; Gastrointestinal Motility; Humans; Intestinal Absorption; Isoquinolines; Male; Parkinson Disease; Rats; Rats, Wistar | 2012 |
Salsolinol, an endogenous neurotoxin, enhances platelet aggregation and thrombus formation.
Topics: Adrenergic Antagonists; Animals; Blood Platelets; Cell Survival; Chlorides; Cyclic AMP; Disease Models, Animal; Dose-Response Relationship, Drug; Ferric Compounds; Humans; Isoquinolines; Male; Neurotoxins; P-Selectin; Platelet Aggregation; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Serotonin; Thrombosis; Time Factors | 2008 |
Myoelectrical activity of small intestine in rats with experimental Parkinson's disease.
Topics: Animals; Disease Models, Animal; Gastric Dilatation; Gastrointestinal Transit; Intestine, Small; Isoquinolines; Myoelectric Complex, Migrating; Parkinsonian Disorders; Peristalsis; Rats; Rats, Wistar | 2005 |
Dopamine-derived endogenous 1(R),2(N)-dimethyl-6,7-dihydroxy- 1,2,3,4-tetrahydroisoquinoline, N-methyl-(R)-salsolinol, induced parkinsonism in rat: biochemical, pathological and behavioral studies.
Topics: Animals; Behavior, Animal; Biogenic Amines; Corpus Striatum; Disease Models, Animal; Injections; Isoquinolines; Male; Parkinson Disease, Secondary; Rats; Rats, Wistar; Tetrahydroisoquinolines; Tyrosine 3-Monooxygenase | 1996 |
Oxidation of N-methyl(R)salsolinol: involvement to neurotoxicity and neuroprotection by endogenous catechol isoquinolines.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antioxidants; Corpus Striatum; Cycloheximide; Disease Models, Animal; DNA Damage; Dopamine; Homovanillic Acid; Humans; Hydroxyl Radical; Isoquinolines; Male; Necrosis; Neuroblastoma; Neurons; Neurotoxins; Oxidative Stress; Parkinson Disease, Secondary; Posture; Rats; Rats, Wistar; Salsoline Alkaloids; Stereoisomerism; Substantia Nigra; Tetrahydroisoquinolines; Tumor Cells, Cultured | 1998 |